287 research outputs found

    Microbial isoprenoid production

    Get PDF

    ZigBee/ZigBee PRO security assessment based on compromised cryptographic keys

    Get PDF
    Sensor networks have many applications in monitoring and controlling of environmental properties such as sound, acceleration, vibration and temperature. Due to limited resources in computation capability, memory and energy, they are vulnerable to many kinds of attacks. The ZigBee specification based on the 802.15.4 standard, defines a set of layers specifically suited to sensor networks. These layers support secure messaging using symmetric cryptographic. This paper presents two different ways for grabbing the cryptographic key in ZigBee: remote attack and physical attack. It also surveys and categorizes some additional attacks which can be performed on ZigBee networks: eavesdropping, spoofing, replay and DoS attacks at different layers. From this analysis, it is shown that some vulnerabilities still in the existing security schema in ZigBee technology.Les xarxes de sensors tenen moltes aplicacions en el control i la monitorització de les propietats del medi ambient, com ara el so, l¿acceleració, la vibració i la temperatura. A causa dels limitats recursos en la capacitat de càlcul, la memòria i l'energia són vulnerables a molts tipus d'atacs. L'especificació ZigBee basada en l'estàndard 802.15.4, defineix un conjunt de capes, adaptada específicament per a xarxes de sensors. Aquestes capes suporten missatgeria segura mitjançant criptografia simètrica. Aquest article presenta dues formes diferents per agafar la clau de xifrat en ZigBee: atac a distància i atacs físics. TambÊ les enquesta i classifica alguns atacs addicionals que es poden realitzar en les xarxes ZigBee: espionatge, falsificació, reproducció i atacs DoS en les diferents capes. A partir d'aquesta anàlisi, es demostren algunes vulnerabilitats existents en l'esquema de seguretat en tecnologia ZigBee.Las redes de sensores tienen muchas aplicaciones en el control y la monitorización de las propiedades del medio ambiente, como el sonido, la aceleración, la vibración y la temperatura. Debido a los limitados recursos en la capacidad de cålculo, la memoria y la energía son vulnerables a muchos tipos de ataques. La especificación ZigBee basada en el eståndar 802.15.4, define un conjunto de capas, adaptada específicamente para redes de sensores. Estas capas soportan mensajería segura mediante criptografía simÊtrica. Este artículo presenta dos formas diferentes para coger la clave de cifrado en ZigBee: ataque a distancia y ataques físicos. TambiÊn las encuesta y clasifica algunos ataques adicionales que se pueden realizar en las redes ZigBee: espionaje, falsificación, reproducción y ataques DoS en las diferentes capas. A partir de este anålisis, se demuestran algunas vulnerabilidades existentes en el esquema de seguridad en tecnología ZigBee

    Microbial production of next-generation stevia sweeteners

    Get PDF
    BACKGROUND: The glucosyltransferase UGT76G1 from Stevia rebaudiana is a chameleon enzyme in the targeted biosynthesis of the next-generation premium stevia sweeteners, rebaudioside D (Reb D) and rebaudioside M (Reb M). These steviol glucosides carry five and six glucose units, respectively, and have low sweetness thresholds, high maximum sweet intensities and exhibit a greatly reduced lingering bitter taste compared to stevioside and rebaudioside A, the most abundant steviol glucosides in the leaves of Stevia rebaudiana. RESULTS: In the metabolic glycosylation grid leading to production of Reb D and Reb M, UGT76G1 was found to catalyze eight different reactions all involving 1,3-glucosylation of steviol C (13)- and C (19)-bound glucoses. Four of these reactions lead to Reb D and Reb M while the other four result in formation of side-products unwanted for production. In this work, side-product formation was reduced by targeted optimization of UGT76G1 towards 1,3 glucosylation of steviol glucosides that are already 1,2-diglucosylated. The optimization of UGT76G1 was based on homology modelling, which enabled identification of key target amino acids present in the substrate-binding pocket. These residues were then subjected to site-saturation mutagenesis and a mutant library containing a total of 1748 UGT76G1 variants was screened for increased accumulation of Reb D or M, as well as for decreased accumulation of side-products. This screen was performed in a Saccharomyces cerevisiae strain expressing all enzymes in the rebaudioside biosynthesis pathway except for UGT76G1. CONCLUSIONS: Screening of the mutant library identified mutations with positive impact on the accumulation of Reb D and Reb M. The effect of the introduced mutations on other reactions in the metabolic grid was characterized. This screen made it possible to identify variants, such as UGT76G1(Thr146Gly) and UGT76G1(His155Leu), which diminished accumulation of unwanted side-products and gave increased specific accumulation of the desired Reb D or Reb M sweeteners. This improvement in a key enzyme of the Stevia sweetener biosynthesis pathway represents a significant step towards the commercial production of next-generation stevia sweeteners. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12934-016-0609-1) contains supplementary material, which is available to authorized users

    Using qualitative research to develop an elaboration of the TIDieR checklist for interventions to enhance vaccination communication: short report

    Get PDF
    BACKGROUND: The COVID-19 pandemic has led to an increased interest in communication with the public regarding vaccination. Our recent Cochrane qualitative evidence synthesis points to several factors that could influence the implementation and success of healthcare worker communication with older adults about vaccination. However, it is often difficult to assess whether factors identified as potentially important in qualitative studies have been considered in randomized trials because of poor trial reporting. We therefore decided to use our qualitative evidence synthesis findings to encourage better reporting of vaccination communication interventions in trials by developing an elaboration of the TIDieR (Template for Intervention Description and Replication) checklist for intervention reporting. METHODS: We examined the findings from our Cochrane qualitative evidence synthesis on healthcare workers’ perceptions of and experiences with communicating about vaccination with adults over the age of 50 years. We identified factors that could influence the implementation and uptake, and thereby the effectiveness, of vaccination communication interventions. We then drafted a list of the information elements we would need from trial reports to assess whether these factors had been considered in the development of the interventions evaluated in these trials. Finally, we compared our list of information elements to the TIDieR checklist items. We were able to align all of our information elements with the TIDieR items. However, for several of the TIDieR items, we developed a more detailed description to ensure that relevant information would be captured sufficiently in trial reports. RESULTS: We developed elaborations for the following TIDieR items: “Why” (item 2), “What—materials” (item 3), “Who provided” (item 5), “How” (item 6), “Where” (item 7) and “Tailoring” (item 9). CONCLUSIONS: Both qualitative research and trials of intervention effectiveness are critical to furthering our understanding of what works, where, for whom and through which mechanisms. However, a key ingredient for developing this understanding is adequate reporting of intervention design, content and implementation in randomized trials. We hope that this elaboration of the TIDier checklist will improve reporting of interventions in trials focused on vaccine communication with older adults, and thereby enhance the usability of this research for developing future communication strategies

    Bayesian sample sizes for exploratory clinical trials comparing multiple experimental treatments with a control

    Full text link
    In this paper, a Bayesian approach is developed for simultaneously comparing multiple experimental treatments with a common control treatment in an exploratory clinical trial. The sample size is set to ensure that, at the end of the study, there will be at least one treatment for which the investigators have a strong belief that it is better than control, or else they have a strong belief that none of the experimental treatments are substantially better than control. This criterion bears a direct relationship with conventional frequentist power requirements, while allowing prior opinion to feature in the analysis with a consequent reduction in sample size. If it is concluded that at least one of the experimental treatments shows promise, then it is envisaged that one or more of these promising treatments will be developed further in a definitive phase III trial. The approach is developed in the context of normally distributed responses sharing a common standard deviation regardless of treatment. To begin with, the standard deviation will be assumed known when the sample size is calculated. The final analysis will not rely upon this assumption, although the intended properties of the design may not be achieved if the anticipated standard deviation turns out to be inappropriate. Methods that formally allow for uncertainty about the standard deviation, expressed in the form of a Bayesian prior, are then explored. Illustrations of the sample sizes computed from the new method are presented, and comparisons are made with frequentist methods devised for the same situation.Comment: 28 pages, 3 tables, 2 figure
    • …
    corecore